HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients.

Abstract
Ganciclovir (GCV) is the cornerstone of cytomegalovirus prevention and treatment in transplant patients. It is associated with problematic adverse hematological effects in this population of immunosuppressed patients, which may lead to dose reduction thus favoring resistance. GCV crosses the membranes of cells, is activated by phosphorylation, and then stops the replication of viral DNA. Its intracellular accumulation might favor host DNA polymerase inhibition, hence toxicity. Following this hypothesis, we investigated the association between a selected panel of membrane transporter polymorphisms and the evolution of neutrophil counts in n=174 renal transplant recipients. An independent population of n=96 renal transplants served as a replication and experiments using HEK293T-transfected cells were performed to validate the clinical findings. In both cohorts, we found a variant in ABCC4 (rs11568658) associated with decreased neutrophil counts following valganciclovir (GCV prodrug) administration (exploratory cohort: β±SD=-0.68±0.28, p=0.029; replication cohort: β±SD=-0.84±0.29, p=0.0078). MRP4-expressing cells showed decreased GCV accumulation as compared to negative control cells (transfected with an empty vector) (-61%; p<0.0001). The efflux process was almost abolished in cells expressing MRP4 rs11568658 variant protein. Molecular dynamic simulations of GCV membrane crossing showed a preferred location of the drug just beneath the polar head group region, which supports its interaction with efflux transporters.
AuthorsPierre-André Billat, Tahani Ossman, Franck Saint-Marcoux, Marie Essig, Jean-Philippe Rerolle, Nassim Kamar, Lionel Rostaing, Hannah Kaminski, Gabin Fabre, Michal Otyepka, Jean-Baptiste Woillard, Pierre Marquet, Patrick Trouillas, Nicolas Picard
JournalPharmacological research (Pharmacol Res) Vol. 111 Pg. 501-508 (09 2016) ISSN: 1096-1186 [Electronic] Netherlands
PMID27402191 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 Elsevier Ltd. All rights reserved.
Chemical References
  • ABCC4 protein, human
  • Antiviral Agents
  • Multidrug Resistance-Associated Proteins
  • Ganciclovir
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiviral Agents (adverse effects, pharmacokinetics, therapeutic use)
  • Cytomegalovirus Infections (prevention & control)
  • Female
  • Ganciclovir (adverse effects, pharmacokinetics)
  • HEK293 Cells
  • Humans
  • Jurkat Cells
  • Kidney Transplantation
  • Male
  • Middle Aged
  • Multidrug Resistance-Associated Proteins (genetics, metabolism)
  • Neutropenia (chemically induced, genetics, metabolism)
  • Polymorphism, Single Nucleotide
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: